# Healthcare Sector
> Hospital chains scaling bed capacity while diagnostics benefit from preventive health awareness and insurance penetration.

## Overview
Market Cap: ₹2,82,553 Cr
Avg P/E: 33.7
Avg ROE: 10.0%
Avg ROCE: 8.2%
1Y Return: +4.37%
Companies: 44

## Data Freshness
Sector Updated: 2026-05-22T07:41:16.091Z
Updated By: daily market-close sync and live stock-data refresh

## Companies
- Lenskart Solutions Ltd (LENSKART): ₹513.95 | PE 136.81 | MCap ₹81,140 Cr
- Dr. Lal PathLabs Ltd (LALPATHLAB): ₹1630.1 | PE 51.91 | MCap ₹27,374 Cr
- Inventurus Knowledge Solutions Ltd (IKS): ₹1585.9 | PE 37.65 | MCap ₹26,681 Cr
- Sai Life Sciences Ltd (SAILIFE): ₹1113.8 | PE 69.6 | MCap ₹23,346 Cr
- Sagility Ltd (SAGILITY): ₹41.24 | PE 20.77 | MCap ₹19,250 Cr
- Syngene International Ltd (SYNGENE): ₹461.85 | PE 53.41 | MCap ₹18,716 Cr
- Poly Medicure Ltd (POLYMED): ₹1598.2 | PE 42.59 | MCap ₹14,769 Cr
- Dr. Agarwals Health Care Ltd (AGARWALEYE): ₹479.35 | PE 111.62 | MCap ₹14,010 Cr
- Vijaya Diagnostic Centre Ltd (VIJAYA): ₹1227.1 | PE 77.78 | MCap ₹13,405 Cr
- Indegene Ltd (INDGN): ₹508.55 | PE 27.99 | MCap ₹12,256 Cr
- Metropolis Healthcare Ltd (METROPOLIS): ₹518.95 | PE 55.15 | MCap ₹10,520 Cr
- Thyrocare Technologies Ltd (THYROCARE): ₹465.85 | PE 44.07 | MCap ₹7,197 Cr
- Fischer Medical Ventures Ltd (FISCHER): ₹36.48 | PE 59.15 | MCap ₹2,284 Cr
- Vimta Labs Ltd-$ (VIMTALABS): ₹451.55 | PE 26.18 | MCap ₹2,011 Cr
- Krsnaa Diagnostics Ltd (KRSNAA): ₹562.55 | PE 23.15 | MCap ₹1,837 Cr
- Suraksha Diagnostic Ltd (SURAKSHA): ₹313.2 | PE 49.04 | MCap ₹1,594 Cr
- Laxmi Dental Ltd (LAXMIDENTL): ₹249.28 | PE 48.51 | MCap ₹1,123 Cr
- Tarsons Products Ltd (TARSONS): ₹218.71 | PE 54.05 | MCap ₹1,104 Cr
- Fabtech Technologies Ltd (FABTECH): ₹151.14 | PE 15.04 | MCap ₹669 Cr
- Hemant Surgical Industries Ltd (HSIL): ₹407.7 | PE 56.78 | MCap ₹532 Cr
- Universus Photo Imagings Ltd (UNIVPHOTO): ₹423 | PE 0 | MCap ₹511 Cr
- Prevest Denpro Ltd (PREVEST): ₹404.1 | PE 24.45 | MCap ₹485 Cr
- Qualitek Labs Ltd (QLL): ₹355 | PE 37.06 | MCap ₹354 Cr
- Nureca Ltd (NURECA): ₹272.2 | PE 24.57 | MCap ₹259 Cr
- Earkart Ltd (EARKART): ₹148.75 | PE 29.75 | MCap ₹205 Cr
- Star Imaging And Path Lab Ltd (STARIMAGIN): ₹72.48 | PE 6.41 | MCap ₹126 Cr
- Modern Diagnostic & Research Centre Ltd (MDRC): ₹81 | PE 13.64 | MCap ₹122 Cr
- Aspira Pathlab & Diagnostics Ltd (ASPIRA): ₹90.99 | PE 65.93 | MCap ₹94 Cr
- Choksi Asia Ltd (CHOKSI): ₹134 | PE 15.2 | MCap ₹79 Cr
- Maestros Electronics & Telecommunications Systems Ltd (METSL): ₹136.9 | PE 12.58 | MCap ₹74 Cr
- Choksi Laboratories Ltd (CHOKSILA): ₹101 | PE 39.29 | MCap ₹73 Cr
- Amkay Products Ltd (AMKAY): ₹59.99 | PE 14.81 | MCap ₹52 Cr
- Shree Pacetronix Ltd (SHREEPAC): ₹127 | PE 19.88 | MCap ₹51 Cr
- KMS Medisurgi Ltd (KMSMEDI): ₹132.8 | PE 74.19 | MCap ₹44 Cr
- Centenial Surgical Suture Ltd (CSURGSU): ₹94 | PE 0 | MCap ₹36 Cr
- Samsrita Labs Ltd (SAMSRITA): ₹15.3 | PE 0 | MCap ₹36 Cr
- Deep Health AI India Ltd (DEEPAI): ₹2.21 | PE 5.18 | MCap ₹34 Cr
- GKB Ophthalmics Ltd (GKB): ₹63.55 | PE 0 | MCap ₹32 Cr
- Adeshwar Meditex Ltd (ADESHWAR): ₹16.43 | PE 12.54 | MCap ₹24 Cr
- Vanta Bioscience Ltd (VANTABIO): ₹18 | PE 0 | MCap ₹13 Cr
- Dolphin Medical Services Ltd (DOLPHMED): ₹6.83 | PE 0 | MCap ₹10 Cr
- Clinitech Laboratory Ltd (CTLLAB): ₹39.5 | PE 12.95 | MCap ₹9 Cr
- Dr Lalchandani Labs Ltd (DLCL): ₹9.67 | PE 12.56 | MCap ₹6 Cr
- Gian Life Care Ltd (GIANLIFE): ₹6.05 | PE 0 | MCap ₹6 Cr

## Analysis
India's healthcare sector is valued at $372 billion and growing at 15-20% annually. Hospital bed density at 1.3 per 1,000 people is among the lowest globally, creating a massive expansion opportunity. Listed hospital chains (Apollo, Max, Fortis) are adding beds aggressively while improving ARPOB (Average Revenue Per Occupied Bed). Medical tourism brings $9 billion annually with India offering procedures at 1/10th the cost of the US. Health insurance penetration is rising rapidly from a low base, making healthcare more accessible. Key metrics: ARPOB, occupancy rates, bed additions, and payor mix (insurance vs out-of-pocket). The sector trades at premium valuations (40-60x PE) due to scarcity and structural tailwinds.

---
Source: rupiya.io/sectors/healthcare
Disclaimer: For research and education only. Not investment advice.